188 related articles for article (PubMed ID: 23873856)
1. Inhibition of GluN2A-containing N-methyl-D-aspartate receptors by 2-naphthoic acid.
Yu H; Popescu GK
Mol Pharmacol; 2013 Oct; 84(4):541-50. PubMed ID: 23873856
[TBL] [Abstract][Full Text] [Related]
2. Structural basis of subunit selectivity for competitive NMDA receptor antagonists with preference for GluN2A over GluN2B subunits.
Lind GE; Mou TC; Tamborini L; Pomper MG; De Micheli C; Conti P; Pinto A; Hansen KB
Proc Natl Acad Sci U S A; 2017 Aug; 114(33):E6942-E6951. PubMed ID: 28760974
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships for allosteric NMDA receptor inhibitors based on 2-naphthoic acid.
Costa BM; Irvine MW; Fang G; Eaves RJ; Mayo-Martin MB; Laube B; Jane DE; Monaghan DT
Neuropharmacology; 2012 Mar; 62(4):1730-6. PubMed ID: 22155206
[TBL] [Abstract][Full Text] [Related]
4. A novel family of negative and positive allosteric modulators of NMDA receptors.
Costa BM; Irvine MW; Fang G; Eaves RJ; Mayo-Martin MB; Skifter DA; Jane DE; Monaghan DT
J Pharmacol Exp Ther; 2010 Dec; 335(3):614-21. PubMed ID: 20858708
[TBL] [Abstract][Full Text] [Related]
5. Molecular Mechanism of Disease-Associated Mutations in the Pre-M1 Helix of NMDA Receptors and Potential Rescue Pharmacology.
Ogden KK; Chen W; Swanger SA; McDaniel MJ; Fan LZ; Hu C; Tankovic A; Kusumoto H; Kosobucki GJ; Schulien AJ; Su Z; Pecha J; Bhattacharya S; Petrovski S; Cohen AE; Aizenman E; Traynelis SF; Yuan H
PLoS Genet; 2017 Jan; 13(1):e1006536. PubMed ID: 28095420
[TBL] [Abstract][Full Text] [Related]
6. Properties of Triheteromeric
Yi F; Zachariassen LG; Dorsett KN; Hansen KB
Mol Pharmacol; 2018 May; 93(5):453-467. PubMed ID: 29483146
[No Abstract] [Full Text] [Related]
7. Synaptic NMDA receptors in basolateral amygdala principal neurons are triheteromeric proteins: physiological role of GluN2B subunits.
Delaney AJ; Sedlak PL; Autuori E; Power JM; Sah P
J Neurophysiol; 2013 Mar; 109(5):1391-402. PubMed ID: 23221411
[TBL] [Abstract][Full Text] [Related]
8. Distinct functional and pharmacological properties of Triheteromeric GluN1/GluN2A/GluN2B NMDA receptors.
Hansen KB; Ogden KK; Yuan H; Traynelis SF
Neuron; 2014 Mar; 81(5):1084-1096. PubMed ID: 24607230
[TBL] [Abstract][Full Text] [Related]
9. Chimeric Glutamate Receptor Subunits Reveal the Transmembrane Domain Is Sufficient for NMDA Receptor Pore Properties but Some Positive Allosteric Modulators Require Additional Domains.
Wilding TJ; Lopez MN; Huettner JE
J Neurosci; 2016 Aug; 36(34):8815-25. PubMed ID: 27559165
[TBL] [Abstract][Full Text] [Related]
10. Mechanism and properties of positive allosteric modulation of N-methyl-d-aspartate receptors by 6-alkyl 2-naphthoic acid derivatives.
Sapkota K; Irvine MW; Fang G; Burnell ES; Bannister N; Volianskis A; Culley GR; Dravid SM; Collingridge GL; Jane DE; Monaghan DT
Neuropharmacology; 2017 Oct; 125():64-79. PubMed ID: 28709671
[TBL] [Abstract][Full Text] [Related]
11. The Negative Allosteric Modulator EU1794-4 Reduces Single-Channel Conductance and Ca
Perszyk RE; Zheng Z; Banke TG; Zhang J; Xie L; McDaniel MJ; Katzman BM; Pelly SC; Yuan H; Liotta DC; Traynelis SF
Mol Pharmacol; 2021 May; 99(5):399-411. PubMed ID: 33688039
[TBL] [Abstract][Full Text] [Related]
12. Subunit-specific effects of poricoic acid A on NMDA receptors.
Lee J; Kim C; Yeom HD; Nguyen KVA; Eom S; Lee S; Jung JH; Lee JH; Kim SH; Kim IK; Lee JH
Pharmacol Rep; 2020 Apr; 72(2):472-480. PubMed ID: 32048268
[TBL] [Abstract][Full Text] [Related]
13. Structure-based discovery of antagonists for GluN3-containing N-methyl-D-aspartate receptors.
Kvist T; Greenwood JR; Hansen KB; Traynelis SF; Bräuner-Osborne H
Neuropharmacology; 2013 Dec; 75():324-36. PubMed ID: 23973313
[TBL] [Abstract][Full Text] [Related]
14. Disruption of S2-M4 linker coupling reveals novel subunit-specific contributions to N-methyl-d-aspartate receptor function and ethanol sensitivity.
Hughes BA; Woodward JJ
Neuropharmacology; 2016 Jun; 105():96-105. PubMed ID: 26577016
[TBL] [Abstract][Full Text] [Related]
15. Effects of competitive NMDA receptor antagonists on excitatory amino acid-evoked currents in mouse spinal cord neurones.
D'Hooge R; Raes A; Van de Vijver G; Van Bogaert PP; De Deyn PP
Fundam Clin Pharmacol; 1999; 13(1):67-74. PubMed ID: 10027090
[TBL] [Abstract][Full Text] [Related]
16. Ifenprodil effects on GluN2B-containing glutamate receptors.
Amico-Ruvio SA; Paganelli MA; Myers JM; Popescu GK
Mol Pharmacol; 2012 Dec; 82(6):1074-81. PubMed ID: 22936815
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the structural requirements for N-methyl-D-aspartate receptor positive and negative allosteric modulators based on 2-naphthoic acid.
Irvine MW; Fang G; Sapkota K; Burnell ES; Volianskis A; Costa BM; Culley G; Collingridge GL; Monaghan DT; Jane DE
Eur J Med Chem; 2019 Feb; 164():471-498. PubMed ID: 30622023
[TBL] [Abstract][Full Text] [Related]
18. GluN1 splice variant control of GluN1/GluN2D NMDA receptors.
Vance KM; Hansen KB; Traynelis SF
J Physiol; 2012 Aug; 590(16):3857-75. PubMed ID: 22641781
[TBL] [Abstract][Full Text] [Related]
19. Effects of ethanol on GluN1/GluN2A and GluN1/GluN2B NMDA receptor-ion channel gating kinetics.
Peoples RW; Ren H
Alcohol Clin Exp Res; 2022 Dec; 46(12):2203-2213. PubMed ID: 36305341
[TBL] [Abstract][Full Text] [Related]
20. Local constraints in either the GluN1 or GluN2 subunit equally impair NMDA receptor pore opening.
Talukder I; Wollmuth LP
J Gen Physiol; 2011 Aug; 138(2):179-94. PubMed ID: 21746848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
